Current topics in the news regarding human immodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS).
- Recording of the HIV/Hepatitis 2013 Data Release webinar presentation (4/30/2014)
- Streaming (12MB)/47 minutes) (NOTE: FireFox or Google Chrome browser recommended. May not work in IE. If you require this in a different format, please contact us at 651-201-5414.)
- Slides: 2013 HIV (PDF: 13MB/105 slides) or (PPT: 15MB/105 slides)
STD Surveillance Statistics
Graphs, tables and text that describe trends in sexually transmitted diseases (STDs) in Minnesota. Includes data on: Chlamydia, Gonorrhea, Syphilis and Chancroid.
2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | Archive
- Recording of the 2013 STD Surveillance Statistics webinar presentation (4/16/2014)
- Streaming (10.45MN/43 minutes) (NOTE: FireFox or Google Chrome browser recommended. May not work in IE. If you require this in a different format, please contact us at 651-201-5414.)
- Slides: 2013 Data (PDF: 2.8MB/59 slides) or (PPT: 5.2MB/59 slides)
Minnesota Treatment Cascade for People Living with HIV/AIDS -
As part of the National HIV/AIDS Strategy for the United States, MDH has calculated an HIV treatment cascade using HIV surveillance data. These calculations help us better understand the HIV epidemic and the disparities that exist in the delivery of care among HIV positive people in Minnesota.
Shigellosis Fact Sheet for Men who have Sex with Men (MSM)
(PDF: 24KB/ 2 pages)
The Minnesota Department of Health (MDH) has observed an increase in reported shigellosis infections in Minneapolis among men who have sex with men (MSM). Four (4) cases were diagnosed in November among white, non-Hispanic, MSM. Sexual contact is the likely route of transmission. Three cases were hospitalized, and two of the cases had been previously diagnosed with HIV infection.
MCH Field Experience, Summer 2013: Developing the protocol for the Fetal and Infant Mortality Review as it relates to perinatal transmission of HIV in Minnesota (FIMR/HIV):
Article at the University of Minnesota's Center for Leadership Education in Material and Child Public Health.
Epidemiological Profile of HIV/AIDS in Minnesota
The epidemiological (epi) profile presents data on the HIV epidemic in the state of Minnesota. The profile is intended to give the Community Cooperative Council on HIV/AIDS Prevention (CCCHAP) and the Minnesota HIV Services Planning Council (Planning Council).
Two New MMWRs Were Recently Added to the Centers for Disease Control and Prevention (CDC) HIV Website
- New MMWR: HIV Testing and Risk Behaviors Among Gay, Bisexual, and Other Men Who Have Sex with Men — United States
- New MMWR: Differences Between HIV-Infected Men and Women in Antiretroviral Therapy Outcomes — Six African Countries, 2004–2012
Update to CDC’s 2010 STD Treatment Guidelines: Oral Cephalosporins No Longer Recommended Treatment for GC Infections
On August 9, 2012 the U.S. Centers for Disease Control and Prevention published “Update to CDC’s Sexually Transmitted Diseases Treatment 2010 Guidelines: Oral Cephalosporins No Longer A Recommended Treatment for Gonococcal Infections,” in Morbidity and Mortality Weekly Report. The most significant change is that CDC now recommends a dual therapy of injectable ceftriaxone in combination with a second antibiotic. CDC no longer recommends an exclusively oral treatment regimen for gonorrhea.
HIV/AIDS among Men Who Have Sex with Men in Minnesota
Men who have sex with men (MSM) and men who have sex with men and use injection drugs (MSM/IDU) remain at increased risk for HIV infection in MN.
Minnesota Chlamydia Strategy: Action Plan to Reduce and Prevent Chlamydia in Minnesota
The Minnesota Chlamydia Partnership (MCP) and the STD, HIV and TB Section of the Minnesota Department of Health (MDH) present the Strategy for Reducing and Preventing Chlamydia in Minnesota, the first-ever action plan to address the epidemic of the sexually transmitted disease chlamydia
Dear Colleague: The Minnesota Department of Health (MDH) requests that you take a sexual history screen for syphilis, provide prevention counseling, and solicit partners when appropriate for all your male patients in light of an alarming 87 percent increase in early syphilis cases. Dated 02/2010. (PDF: 32KB/1 page)
CDC’s STD Treatment Guidelines for the treatment of persons who have or are at risk for sexually transmitted diseases (STDs).
STD Treatment Guidelines: http://www.cdc.gov/std/treatment/
- The MMWR of the 2010 STD Treatment Guidelines published electronically on December 17, 2010 contains incorrect dosage information. MMWR will issue an erratum by January 14, 2011. Three significant corrections pertain to the recommended regimens for gonococcal infections, which include gonococcal dual therapy, and the alternative regimens for bacterial vaginosis.
- Corrected pages to the print version (pages 50, 51, and 57) of the MMWR are available on the CDC Division of STD Prevention website at http://www.cdc.gov/std/treatment/.
Dear Colleague: The Minnesota Department of Health (MDH) would like to alert you to a 31 percent increase in new syphilis cases for 2010 compared to the same time period last year. Dated 9/27/2010. (PDF: 33KB/1 page)
The Minnesota Chlamydia Partnership (MCP)
A Summit on Chlamydia was be held on Tuesday, August 3, 2010 to kick-off the MCP. Professional and community experts describe the epidemic of chlamydia and discuss the complex issues surrounding it.
Minnesota African/African-American W MAAAH was formed to establish Black women as a funding priority in the State of Minnesota, address the issue of lack of services specific to Black women and youth, and to ensure sustainability of services for Black women.
STD/HIV Laboratory Survey
In 2008, MDH conducted a survey of 120 laboratories to assess STD testing and reporting practices. The results for chlamydia, gonorrhea, syphilis and HIV testing and reporting practices from survey respondents are now available.
CDC's Morbidity and Mortality Weekly Report (MMWR)
This issue of MMWR describes the HIV/AIDS epidemic in the United States and notes important successes and current challenges in the prevention of HIV. Also includes the summary Twenty-Five Years of HIV/AIDS - United States, 1981-2006.
HIV Subtype and Drug Resistance Surveillance
MDH, STD, HIV and TB Section and Public Health Laboratory have incorporated HIV drug resistance and subtype surveillance into routine HIV surveillance.
Twin Cities Men's Health Survey
Results of the MDH survey of health and sexual behaviors of men conducted during the 2004 Twin Cities GLBT Pride celebration in Minneapolis.
Content Notice: This site contains HIV or STD prevention messages that may not be appropriate for all audiences. Since HIV and other STDs are spread primarily through sexual practices or by sharing needles, prevention messages and programs may address these topics. If you are not seeking such information or may be offended by such materials, please exit this web site.